Amid a surge in COVID-19 cases, China on Tuesday reported 1,629 new coronavirus cases, the National Health Commission's Wednesday report showed.
Out of 1,629 infections, 1,565 were locally transmitted cases and 64 were imported COVID-19 cases, reported Xinhua.
Of the new local infections, 1,150 were reported in Jilin, 326 in Shanghai, 26 in Henan, and 16 in Heilongjiang.
The rest of the cases were reported in 15 other provincial-level regions, according to the commission.
A total of 64 imported COVID-19 cases were reported Tuesday, said the commission. It added that two suspected cases arriving from outside the mainland were reported in Shanghai and no new deaths from COVID-19 were reported on the day.
Meanwhile, China's much-publicised 'zero-covid' strategy that the government credited for bringing the country out of the pandemic till recently is falling apart as the rapidly mounting cases are again forcing mass lockdowns like those seen in 2020.
Amid growing resentment over the stringent measures towards the zero-COVID policy by the authorities, the Chinese public has been taking to social media platforms to express their frustration and discontentment.
Netizens have been complaining that excessive measures such as the imposition of complete lockdown and frequent and expansive tests have been causing widespread suffering, including financial/economic loss, reported local media.
China has clung to a zero-tolerance approach to the virus that relies on stringent lockdowns, mass testing and quarantine in government facilities.
Earlier, Chinese President Xi Jinping has said that Beijing will stick to its "zero Covid-19" policy, days after National Health Commission (NHC) released new guidelines easing its control measures.
NHC had uploaded a new document on its website. Titled the Novel Coronavirus Diagnosis And Treatment Plan, it was the ninth revision to a document setting out the COVID-19 policy for the country of 1.4 billion.
China's zero-COVID policy is pushing cash-strapped local governments to the brink amid rising health care costs and efforts to control debt.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)